Bassé, et al., “Isolation of an Erythrocyte Membrane Protein that Mediates Ca2+-dependent Transbilayer Movement of Phospholipid,” The Journal of Biological Chemistry 271(29):17205-17210, 1996. |
Bevers, et al., “Platelet Procoagulant Activity: Physiological Significance an Mechanisms of Exposure,” Blood Reviews 5:146-154, 1991. |
Bevers, et al., “Defective Ca2+-Induced Microvesiculation and Deficient Expression of Procoagulant Activity in Erythrocytes From a Patient With a Bleeding Disorder: A Study of the Red Blood Cells of Scott Syndrome,” Blood 79(2):380-388, 1992. |
Bevers, et al., “The Complex of Phosphatidylinositol 4,5-Bisphosphate and Calcium Ions Is Not Responsible for Ca2+-Induced Loss of Phospholipid Asymmetry in the Human Erythrocyte: A Study in Scott Syndrome, a Disorder of Calcium-Induced Phospholipid Scrambling,” Blood 86(5):1983-1991, 1995. |
Bruckheimer, et al., “Membrane phospholipid asymmetry: host response to the externalization of phosphatidylserine,” Journal of Leukocyte Biology 59:784-788, 1996. |
Chang, et al., “Contribution of Platelet Microparticle Formation and Granule Secretion to the Transmembrane Migration of Phosphatidylserine,” The Journal of Biological Chemistry 268(10):7171-7178, 1993. |
Comfurius, et al., “Reconstitution of Phospholipid Scramblase Activity from Human Blood Platelets,” Biochemistry 35(24):7631-7634, 1996. |
Dachary-Prigent, et al., “Physiopathological Significance of Catalytic Phospholipids in the Generation of Thrombin,” Seminars in Thrombosis and Hemostasis 22:157-164, 1996. |
Devaux, et al, “Maintenance and consequences of membrane phospholipid asymmetry,, ” Chem. Phys. Lipids vol. 73, pp. 107-120, 1994. |
Diaz, et al., “Generation of Phenotypically Aged Phosphatidylserine-Expressing Erythrocyted by Dilauroylphosphatidylcholine-Induced Vesiculationk” Blood 87(7):2956-2961, 1996. |
Fadok, et al., “Exposure of Phosphatidylserine on the Surface of Apoptotic Lymphocytes Triggers Specific Recognition and Removal of Macrophages,” The Journal of Immunology 148(7):2207-2216, 1992. |
Gaffet, et al., “Loss of phospholipid asymmetry in human platelet plasma membrane after 1-12 days of storage,” Eur. J. Biochem. 222:1033-1040, 1994. |
Hamilton, et al., “Complement Proteins C5b-9 Induce Vesiculation of the Endothelial Plasma Membrane and Expose Catalytic Surface for Assembly of the Prothrombinase Enzyme Complex,” The Journal of Biological Chemistry 265(7):3809-3814, 1990. |
Kasukabe, et al., TRA1, a Novel mRNA Highly Expressed in Leukemogenic Mouse Monocytic Sublines But Not in Nonleukemogenic Sublines, Blood 89(8):2975-2985, 1997. |
Kennedy, et al., “Protection of Porcine Aortic Endothelial Cells from Complement-Mediated Cell Lysis and Activation by Recombinant Human CD59,” Transplantation 57(10):1494-1501, 1994. |
Kojima, et al., “Production and Characterization of Transformed B-Lymphocytes Expressing the Membrane Defect of Scott Syndrome,” J. Clin. Invest. 94:2237-2244, 1994. |
Koopman, et al., “Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis,” Blood 84(5):1415-1420, 1994. |
Martin, et al., “Early Redistribution of Plasma Membrane Phosphatidylserine Is a General Feature of Apoptosis Regardless of the Initiating Stimulus: Inhibition by Overexpression of Bc1-2 and Abl,” J. Exp. Med. 182:1545-1556, 1995. |
McIntyre, et al., “Fluorescence Assay for Phospholipid Membrane Assymmetry,” Biochemistry 30(51):11819-11827, 1991. |
Miletich, et al., “Deficiency of Factor X1-Factor Va Binding Sites on the Platelets of a Patient With a Bleeding Disorder,” Blood 54(5):1015-1022, 1979. |
Sims, et al., “Complement Proteins C5b-9 Cause Release of Membrane Vesicles from the Platelet Surface That Are Enriched in the Membrane Receptor for Coagulation Factor Va and Express Prothrombinase Activity,” The Journal of Biological Chemistry 263(34):18205-18212, 1988. |
Sims, et al., “Assembly of the Platelet Prothrombinase Complex is Linked to Vesiculation of the Platelet Plasma Membrane,” The Journal of Biological Chemistry 264(29):17049-17057, 1989. |
Sims, et al., “Regulatory Control of Complement on Blood Platelets,” The Journal of Biological Chemistry 264(32):19228-19235, 1989. |
Sims, et al, “Induction of Cellular Procoagulant Activity by the Membrane Attack Complex of Complement,” Seminars in Cell Biology (6):275-282, 1995. |
Smeets, et al., “Calcium-induced transbilayer scrambing of fluorescent phospholipid analogs in platelets and erythrocytes,,” Biochem. Biophys. Acta. vol. 1195, pp. 281-286, 1994. |
Toti, et al., “Scott Syndrome, Characterized by Impaired Transmembrane Migration of Procoagulant Phosphatidylserine and Hemorrhagic Complications, Is an Inherited Disorder,”, Blood 87(4):1409-1415, 1996. |
Verhoven, et al., “Mechanisms of Phosphatidylserine Exposure, A Phagocyte Recognition Signal, or Apoptotic T Lymphocytes,” J. Exp. Med. 182:1597-1601, 1995. |
Wang, et al., “Activation of the Alternative Complement Pathway by Exposure of Phosphatidylethanolamine and Phosphatidylserine on Erythrocytes from Sickle Cell Disease Patients,” J. Clin. Invest. 92:1326-1335, 1993. |
Weiss, “Scott Syndrome: A Disorder of Platelet Coagulant Activity,” Seminars in Hematology 31(4):312-319, 1994. |
Weiss, et al., “Platelet Prothrombinase Activity and Intracellular Calcium Responses in Patients With Storage Pool Deficiency, Glycoprotein IIb-IIIa Deficiency, or Impaired Platelet Coagulant Activity—A Comparison With Scott Syndrome,” Blood 89(5):1599-1611, 1997. |
Wiedmer, et al., “On the Mechanism by Which Complement Proteins C5b-9 Increase Platelet Prothrombinase Activity,” The Journal of Biological Chemistry 261(31):14587-14592, 1986. |
Wiedmer, et al., “Complement Proteins C5b-9 Stimulates Procoagulant Activity Through Platelet Prothrombinase,” Blood 68(4):875-880, 1986. |
Wiedmer, et al., “Role of Calcium and Calpain in Complement-Induced Vesiculation of the Platelet Plasma Membrane and in the Exposure of the Platelet Factor Va Receptor,” American Chemical Society 29(3):623-632, 1990. |
Wiedman, et al., “Participation of Protein Kinase in Complement C5b-9-Induced Shedding of Platelet plasma Membrane Vesicles,” Blood 78(11):2880-2886, 1991. |
Wiedman, et al., “Complement-Induced Vesiculation and Exposure of Membrane Prothrombinase Sites in Platelets of Peroxysmal Nocturnal Hemoglobinuria,” Blood 82(4):1192-1196, 1993. |
Williamson, et al., “Continuous Analysis of the Mechanism of Activated Transbilayer Lipod Movement in Platelets,” Biochemistry 34(33):10448-10455, 1995. |
Wood, et al., “Increased Erythrocyte Phosphatidylserine Exposure in Sickle Cell Disease: Flow-Cytometric Measurement and Clinical Associations,” Blood 88(5):1873-1880, 1996. |
Database, Medline on STN, No. 90158550, Zwall, et al., “Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled cells; mechanisms and physiological significance,” Mol. Cell. Biochem. vol. 1-2, pp. 23-31, 1989. |
Zwall, et al., “Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells,” Blood 89(4):1121-1132, 1997. |